Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 13 | 2021 | 418 | 1.890 |
Why?
|
| Epilepsy | 7 | 2020 | 336 | 1.620 |
Why?
|
| Drug Resistant Epilepsy | 7 | 2020 | 44 | 1.460 |
Why?
|
| Epilepsy, Temporal Lobe | 10 | 2020 | 138 | 1.410 |
Why?
|
| Athletic Injuries | 3 | 2014 | 73 | 1.320 |
Why?
|
| Status Epilepticus | 6 | 2020 | 74 | 1.210 |
Why?
|
| Brain Concussion | 2 | 2014 | 27 | 0.900 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2021 | 9 | 0.820 |
Why?
|
| Seizures | 4 | 2021 | 279 | 0.790 |
Why?
|
| Brain Diseases | 1 | 2021 | 78 | 0.780 |
Why?
|
| Anticonvulsants | 4 | 2020 | 223 | 0.760 |
Why?
|
| Temporal Lobe | 5 | 2020 | 125 | 0.750 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2020 | 12 | 0.720 |
Why?
|
| Electric Stimulation Therapy | 5 | 2020 | 147 | 0.580 |
Why?
|
| Coma | 1 | 2016 | 17 | 0.570 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 53 | 0.560 |
Why?
|
| Brain | 6 | 2017 | 2175 | 0.560 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 848 | 0.550 |
Why?
|
| Implantable Neurostimulators | 4 | 2020 | 12 | 0.550 |
Why?
|
| Bupropion | 1 | 2016 | 63 | 0.550 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 503 | 0.540 |
Why?
|
| Drug Overdose | 1 | 2016 | 67 | 0.530 |
Why?
|
| Evidence-Based Nursing | 1 | 2015 | 27 | 0.530 |
Why?
|
| Consumer Health Information | 1 | 2015 | 16 | 0.520 |
Why?
|
| Epilepsies, Partial | 4 | 2020 | 24 | 0.500 |
Why?
|
| Terminology as Topic | 1 | 2015 | 141 | 0.490 |
Why?
|
| Decision Making | 1 | 2017 | 410 | 0.490 |
Why?
|
| Deep Brain Stimulation | 3 | 2020 | 71 | 0.460 |
Why?
|
| Sports | 1 | 2013 | 55 | 0.450 |
Why?
|
| Parents | 1 | 2015 | 309 | 0.430 |
Why?
|
| Cognition Disorders | 1 | 2015 | 342 | 0.420 |
Why?
|
| Neural Tube Defects | 1 | 2010 | 27 | 0.380 |
Why?
|
| Humans | 36 | 2021 | 68525 | 0.380 |
Why?
|
| Monitoring, Intraoperative | 1 | 2010 | 53 | 0.370 |
Why?
|
| Brain Injuries | 1 | 2013 | 268 | 0.370 |
Why?
|
| Scoliosis | 1 | 2010 | 42 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 772 | 0.370 |
Why?
|
| Young Adult | 14 | 2021 | 5708 | 0.350 |
Why?
|
| Upper Extremity | 1 | 2010 | 112 | 0.350 |
Why?
|
| Sleep Wake Disorders | 1 | 2010 | 94 | 0.350 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2017 | 100 | 0.350 |
Why?
|
| Hospitalization | 1 | 2013 | 977 | 0.310 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 711 | 0.280 |
Why?
|
| Connectome | 2 | 2020 | 91 | 0.280 |
Why?
|
| Incidence | 3 | 2015 | 1582 | 0.270 |
Why?
|
| Brain Mapping | 6 | 2017 | 531 | 0.270 |
Why?
|
| Male | 21 | 2020 | 37281 | 0.260 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2020 | 211 | 0.260 |
Why?
|
| Adolescent | 12 | 2020 | 8903 | 0.260 |
Why?
|
| Treatment Outcome | 8 | 2020 | 7028 | 0.250 |
Why?
|
| Female | 21 | 2021 | 38015 | 0.230 |
Why?
|
| Stroke | 1 | 2016 | 2161 | 0.230 |
Why?
|
| Brain Waves | 2 | 2015 | 30 | 0.230 |
Why?
|
| Nerve Net | 3 | 2020 | 180 | 0.230 |
Why?
|
| Quality of Life | 3 | 2020 | 1515 | 0.220 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 98 | 0.220 |
Why?
|
| Adult | 18 | 2020 | 21375 | 0.210 |
Why?
|
| Shoulder Dislocation | 1 | 2021 | 17 | 0.210 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2021 | 31 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2020 | 2222 | 0.200 |
Why?
|
| Joint Instability | 1 | 2021 | 87 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2020 | 689 | 0.190 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 1139 | 0.190 |
Why?
|
| Neuroimaging | 1 | 2021 | 122 | 0.180 |
Why?
|
| Middle Aged | 17 | 2020 | 21119 | 0.180 |
Why?
|
| Shoulder Joint | 1 | 2021 | 110 | 0.180 |
Why?
|
| Infant | 4 | 2016 | 2891 | 0.180 |
Why?
|
| Child, Preschool | 4 | 2016 | 3185 | 0.180 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2020 | 61 | 0.170 |
Why?
|
| Software | 2 | 2012 | 418 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1851 | 0.170 |
Why?
|
| Artifacts | 2 | 2017 | 125 | 0.170 |
Why?
|
| Machine Learning | 1 | 2020 | 170 | 0.170 |
Why?
|
| Hippocampus | 5 | 2015 | 471 | 0.160 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 415 | 0.160 |
Why?
|
| Probability | 1 | 2017 | 244 | 0.150 |
Why?
|
| Neocortex | 1 | 2017 | 17 | 0.150 |
Why?
|
| Depressive Disorder | 2 | 2020 | 621 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2020 | 7264 | 0.140 |
Why?
|
| Child | 4 | 2016 | 6400 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 3256 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2018 | 75 | 0.130 |
Why?
|
| Diet, Ketogenic | 1 | 2015 | 5 | 0.130 |
Why?
|
| Piracetam | 1 | 2015 | 10 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 329 | 0.130 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 22 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 34 | 0.130 |
Why?
|
| Medical Marijuana | 1 | 2015 | 21 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2017 | 383 | 0.130 |
Why?
|
| Fructose | 1 | 2015 | 51 | 0.130 |
Why?
|
| Education, Nursing, Continuing | 1 | 2015 | 27 | 0.130 |
Why?
|
| Demography | 2 | 2013 | 279 | 0.130 |
Why?
|
| Internet | 2 | 2015 | 390 | 0.130 |
Why?
|
| Limbic System | 2 | 2012 | 106 | 0.120 |
Why?
|
| Drug Resistance | 1 | 2015 | 223 | 0.120 |
Why?
|
| Post-Concussion Syndrome | 1 | 2014 | 4 | 0.120 |
Why?
|
| Brain Injury, Chronic | 1 | 2014 | 4 | 0.120 |
Why?
|
| Head Protective Devices | 1 | 2014 | 15 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2015 | 240 | 0.120 |
Why?
|
| Sports Medicine | 1 | 2014 | 22 | 0.120 |
Why?
|
| Epidemiologic Studies | 1 | 2013 | 33 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2264 | 0.120 |
Why?
|
| Trauma Severity Indices | 1 | 2013 | 80 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2015 | 275 | 0.110 |
Why?
|
| Age Distribution | 1 | 2013 | 319 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 174 | 0.110 |
Why?
|
| Electrodes, Implanted | 3 | 2017 | 98 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2013 | 285 | 0.100 |
Why?
|
| Aged | 6 | 2020 | 14842 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 310 | 0.100 |
Why?
|
| Expert Systems | 1 | 2011 | 9 | 0.100 |
Why?
|
| Amnesia | 1 | 2011 | 17 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2017 | 2004 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2013 | 880 | 0.100 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 159 | 0.100 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2010 | 8 | 0.100 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.100 |
Why?
|
| Neurosurgery | 1 | 2011 | 42 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 955 | 0.090 |
Why?
|
| Afferent Pathways | 1 | 2010 | 31 | 0.090 |
Why?
|
| Motor Skills | 1 | 2010 | 88 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2010 | 112 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 333 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 239 | 0.080 |
Why?
|
| Risk Factors | 2 | 2016 | 5719 | 0.070 |
Why?
|
| Atrophy | 3 | 2012 | 112 | 0.070 |
Why?
|
| South Carolina | 1 | 2013 | 2750 | 0.070 |
Why?
|
| Parahippocampal Gyrus | 2 | 2020 | 15 | 0.070 |
Why?
|
| Neurons | 1 | 2012 | 881 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4843 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2017 | 652 | 0.060 |
Why?
|
| Observer Variation | 2 | 2018 | 330 | 0.060 |
Why?
|
| Algorithms | 3 | 2018 | 1194 | 0.060 |
Why?
|
| Dominance, Cerebral | 2 | 2017 | 65 | 0.060 |
Why?
|
| United States | 1 | 2015 | 7335 | 0.050 |
Why?
|
| Shoulder | 1 | 2021 | 37 | 0.050 |
Why?
|
| Neural Pathways | 2 | 2013 | 323 | 0.050 |
Why?
|
| Electrocorticography | 1 | 2020 | 1 | 0.050 |
Why?
|
| Gray Matter | 1 | 2020 | 57 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 80 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 70 | 0.050 |
Why?
|
| Thalamus | 2 | 2010 | 82 | 0.050 |
Why?
|
| ROC Curve | 1 | 2020 | 392 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2020 | 111 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2020 | 84 | 0.040 |
Why?
|
| Suicide | 1 | 2020 | 115 | 0.040 |
Why?
|
| Neurologists | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospitals, Private | 1 | 2018 | 15 | 0.040 |
Why?
|
| Age Factors | 2 | 2016 | 1860 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2020 | 3702 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 70 | 0.040 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 1 | 0.040 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 4 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2017 | 9 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2017 | 53 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 281 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 929 | 0.030 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 7 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2017 | 344 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 536 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 791 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 4655 | 0.030 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2013 | 9 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 166 | 0.030 |
Why?
|
| Perfusion | 1 | 2013 | 131 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1054 | 0.030 |
Why?
|
| Scalp | 1 | 2011 | 47 | 0.020 |
Why?
|
| Honduras | 1 | 2010 | 21 | 0.020 |
Why?
|
| Comprehension | 1 | 2010 | 71 | 0.020 |
Why?
|
| Sclerosis | 1 | 2010 | 32 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 35 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 188 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 1737 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2010 | 77 | 0.020 |
Why?
|
| Language | 1 | 2010 | 120 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2011 | 230 | 0.020 |
Why?
|
| Developing Countries | 1 | 2010 | 106 | 0.020 |
Why?
|
| Cerebellum | 1 | 2010 | 103 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 113 | 0.020 |
Why?
|
| Inpatients | 1 | 2010 | 208 | 0.020 |
Why?
|
| Amygdala | 1 | 2010 | 159 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1548 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 225 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 402 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1465 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2077 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 137 | 0.020 |
Why?
|